The medical device industry defies traditional economic wisdom, revealing a paradox where immense healthcare demand often fails to translate directly into MedTech growth and enterprise value. This is driven by systemic disconnects between patient need and reimbursable care, along with limitations in value capture despite high procedure volumes and the struggle for truly sustainable growth. Successfully navigating this landscape demands a deep understanding of the shift towards value-based care, the industrialization of procurement, and the strategic leverage of digital health.

With AI making software creation effortless, the act of building is no longer a differentiator, commoditizing software itself. True value now lives in clear thinking, proprietary data, effective distribution, and the agility to deliver specific outcomes and build trust, rather than just the underlying code.

When launching something new, we instinctively look to friends and family for support, but their initial silence often stems from their past perception of you, the perceived risk of early public backing, or simply not being your target audience. True belief often emerges from strangers who see your value without history or obligation, solving a problem they recognize. Momentum builds when we stop seeking validation from those closest and instead focus on resonating with our actual audience, understanding that belief follows proof, not proximity.

The convenience of AI for drafting communications might be tempting, but for senior leaders, the risks to reputation and trust are significant. Unreliable AI detection and the public's demand for genuine, personal insights mean that generic, AI-assisted posts can erode credibility. My firm view is that leaders should share their raw thoughts and let human editors shape them, keeping AI for behind-the-scenes support only.